QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Interleukin-1ß (IL-1ß) (Matrix: Human Plasma
Media Mixture)
| Matrix: | Human Plasma Media Mixture |
| Assay Range: | 4 – 500 pg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-1ß (IL-1ß) (Matrix: Human Whole Blood
Supernatant)
| Matrix: | Human Whole Blood Supernatant |
| Assay Range: | 24 – 1,166 pg/mL |
| Sample Volume: | 0.4 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-1ß (IL-1β) (Matrix: Cell Culture Media)
| Matrix: | Cell Culture Media |
| Assay Range: | 5 – 250 pg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-1ß (IL-1β) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 4 – 250 pg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-1ß (IL-1β)High Sensitivity (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 0.125 – 8 pg/mL |
| Sample Volume: | 0.15 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-1ß (IL-1β)Interleukin-10 (IL-10)TNF-α (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 20 – 4,000 pg/mL |
| Sample Volume: | 0.06 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | Luminex (3Plex) |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-4 (IL-4)Interleukin-5 (IL-5) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 9.77 – 2,500 pg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ECL |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-6 (IL-6) (Matrix: Human Whole Blood
Supernatant)
| Matrix: | Human Whole Blood Supernatant |
| Assay Range: | 19 – 2,024 pg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-6 (IL-6) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 3.12 – 300 pg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-6 (IL-6) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 10.547 – 1,350 pg/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | Luminex (3Plex) |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-6 (IL-6) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 3.125 – 300 pg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-6 (IL-6)High Sensitivity (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.16 – 10 pg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Citrate EDTA Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-6 (IL-6)High Sensitivity (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 0.156 – 10.0 pg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-6 (IL-6)High Sensitivity (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 0.16 – 10 pg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-6 soluble receptor(IL-6 sR) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 0.0313 – 2.00 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Interleukin-8 (IL-8) (Matrix: Human Whole Blood Supernatant)
| Matrix: | Human Whole Blood Supernatant |
| Assay Range: | 40 – 1,615 pg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Iodoacetamide (Matrix: Formulation)
| Matrix: | Formulation |
| Assay Range: | 0.250 – 500 µM |
| Sample Volume: | 0.02 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Drug Assays |
IP-10 (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 10 – 500 pg/mL |
| Sample Volume: | 0.075 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-DE |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
IP-10 (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 10 – 500 pg/mL |
| Sample Volume: | 0.15 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Irbesartan (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 6,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Irbesartan (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 2500 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Irbesartan
Hydrochlorothiazide (Matrix: Human Plasma)
Hydrochlorothiazide (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 7,000 ng/mL 8 – 400 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Irinotecan (CPT11)
SN-38 (Matrix: Human Plasma)
SN-38 (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2.00 – 2,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Irinotecan (CTP11)
SN-38 (Matrix: Human Plasma)
SN-38 (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 4,000 ng/mL 2 – 4,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Iron (total)
Iron (free) (Matrix: Human Serum Ultrafiltrate)
Iron (free) (Matrix: Human Serum Ultrafiltrate)
| Matrix: | Human Serum Ultrafiltrate |
| Assay Range: | 2.00-5,000 ng/mL 2.00-150 ng/mL above native |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Drug Assays |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
